Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chitosan Coated Luteolin Nanostructured Lipid Carriers: Optimization, In Vitro-Ex Vivo Assessments and Cytotoxicity Study in Breast Cancer Cells
Sadaf Jamal Gilani, May Bin‐Jumah, Md. Rizwanullah, et al.
Coatings (2021) Vol. 11, Iss. 2, pp. 158-158
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management
Priti Tagde, Agnieszka Najda, Kalpana Nagpal, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2856-2856
Open Access | Times Cited: 96
Luteolin: A flavone with myriads of bioactivities and food applications
Sneh Punia Bangar, Priyanka Kajla, Vandana Chaudhary, et al.
Food Bioscience (2023) Vol. 52, pp. 102366-102366
Closed Access | Times Cited: 58
Chitosan-coated nanostructured lipid carriers for transdermal delivery of tetrahydrocurcumin for breast cancer therapy
Thien Hoang Truong, Khent Primo Alcantara, Bryan Paul I. Bulatao, et al.
Carbohydrate Polymers (2022) Vol. 288, pp. 119401-119401
Closed Access | Times Cited: 64
Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy
Aiswarya Chaudhuri, Dulla Naveen Kumar, Rasheed A. Shaik, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10068-10068
Open Access | Times Cited: 52
Development of Atomoxetine-Loaded NLC In Situ Gel for Nose-to-Brain Delivery: Optimization, In Vitro, and Preclinical Evaluation
Dibyalochan Mohanty, Omar Awad Alsaidan, Ameeduzzafar Zafar, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1985-1985
Open Access | Times Cited: 29
Luteolin, a flavone ingredient: Anticancer mechanisms, combined medication strategy, pharmacokinetics, clinical trials, and pharmaceutical researches
Mingyi Shi, Zixian Chen, Hui Gong, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 2, pp. 880-911
Closed Access | Times Cited: 29
Design, synthesis, and in-Silco ADME prediction of some novel bis(1,3,4-thiadiazoles) encapsulated lipid chitosan nano capsule decorative with magnetic nanoparticles and their potential anti-helicobacter pylori activity
Mostafa E. Salem, Ahmed H. M. Elwahy, Hamdi M. Hassaneen, et al.
International Journal of Biological Macromolecules (2025), pp. 139746-139746
Closed Access | Times Cited: 1
Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application
Md. Rizwanullah, Mohammad Zaki Ahmad, Anuj Garg, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2021) Vol. 1865, Iss. 9, pp. 129936-129936
Closed Access | Times Cited: 43
Application of nanoparticles in breast cancer treatment: a systematic review
Shima Bourang, Mehran Noruzpour, Sodabeh Jahanbakhsh Godekahriz, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 9, pp. 6459-6505
Closed Access | Times Cited: 8
Thymoquinone loaded chitosan - Solid lipid nanoparticles: Formulation optimization to oral bioavailability study
Iqra Rahat, Md. Rizwanullah, Sadaf Jamal Gilani, et al.
Journal of Drug Delivery Science and Technology (2021) Vol. 64, pp. 102565-102565
Closed Access | Times Cited: 37
Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments
Iqra Rahat, Syed Sarim Imam, Md. Rizwanullah, et al.
Drug Delivery (2021) Vol. 28, Iss. 1, pp. 973-984
Open Access | Times Cited: 37
Chitosan-functionalized nanostructured lipid carriers containing chloroaluminum phthalocyanine for photodynamic therapy of skin cancer
Ellen Denise Prado Almeida, Luiz André Santos Silva, Guilherme Rodolfo Souza de Araújo, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2022) Vol. 179, pp. 221-231
Open Access | Times Cited: 22
Chitosan modified 5-fluorouracil nanostructured lipid carriers for treatment of diabetic retinopathy in rats: A new dimension to an anticancer drug
Deep Shikha Sharma, Sheetu Wadhwa, Monica Gulati, et al.
International Journal of Biological Macromolecules (2022) Vol. 224, pp. 810-830
Closed Access | Times Cited: 22
Encapsulation of flavonoids in foods for diabetics: The emerging paradigm for an effective therapy
Williara Queiroz de Oliveira, Iramaia Angélica Neri-Numa, Henrique Silvano Arruda, et al.
Trends in Food Science & Technology (2022) Vol. 127, pp. 198-206
Closed Access | Times Cited: 19
Occurrence of Luteolin in the Greek Flora, Isolation of Luteolin and Its Action for the Treatment of Periodontal Diseases
Athanasios Arampatzis, Aspasia Pampori, E Droutsa, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7720-7720
Open Access | Times Cited: 13
Nano-scale drug delivery systems for luteolin: advancements and applications
Jinlu Shang, Jinglei Yang, Qinmin Deng, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 47, pp. 11198-11216
Closed Access | Times Cited: 12
Leveraging nanostructured lipid carriers to enhance targeted delivery and efficacy in breast cancer therapy: a comprehensive review
Nazish Naseem, Poonam Kushwaha, Faheem Haider
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 398, Iss. 1, pp. 449-468
Closed Access | Times Cited: 4
Recent Developments in Luteolin-Loaded Nanoformulations for Enhanced Anti-Carcinogenic Activities: Insights from In Vitro and In Vivo Studies
Muhammad Redza Fahmi Mod Razif, Siok Yee Chan, Yik-Ling Chew, et al.
Sci (2024) Vol. 6, Iss. 4, pp. 68-68
Open Access | Times Cited: 4
Optimisation of albendazole delivery and assessment of anticancer potential in hepatocellular carcinoma (HepG2 cells) using surface modified nanostructured lipid carriers
Walid Anwar, Abdulsalam M. Kassem, Ayman Salama, et al.
Journal of Microencapsulation (2025), pp. 1-16
Closed Access
Formulation and Evaluation of Apigenin-Loaded Hybrid Nanoparticles
Imran Kazmi, Fahad A. Al‐Abbasi, Syed Sarim Imam, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 783-783
Open Access | Times Cited: 17
Folic acid conjugated-chitosan modified nanostructured lipid carriers as promising carriers for delivery of Umbelliprenin to cancer cells: In vivo and in vitro
Farzaneh Sadeghzadeh, Alireza Motavalizadehkakhky, Jamshid Mehrzad, et al.
European Polymer Journal (2023) Vol. 186, pp. 111849-111849
Closed Access | Times Cited: 10
Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells
Farheen Fatima Qizilbash, Ali Sartaj, Zufika Qamar, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 8, pp. 794-816
Closed Access | Times Cited: 10
Propolis-loaded nanostructured lipid carriers halt breast cancer progression through miRNA-223 related pathways: an in-vitro/in-vivo experiment
Sara A. Shaker, Shadi M. Alshufta, Mennatallah A. Gowayed, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Erlotinib encapsulated oral chitosan modified lipid nanoparticles for lung cancer
Najla Altwaijry, Sadaf Jamal Gilani, Ahlam Sultan, et al.
Journal of Drug Delivery Science and Technology (2025) Vol. 105, pp. 106612-106612
Closed Access
Emerging phytochemical-based nanocarriers: redefining the perspectives of breast cancer therapy
Gulshan Sharma, Rohil Panwar, Sangeeta Saini, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Page 1 - Next Page

Scroll to top